Use of Alternative Therapy in Psoriasis Vulgaris Patients

Psoriasis Vulgaris Clinical Trial

Official title:

Use of Alternative Therapy in Psoriasis Vulgaris Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04207216
• Other study ID #: IstanbulMU6
• Status: Completed
• Start date: January 1, 2020
• Est. completion date: July 1, 2020

Study information

• Verified date: January 2021
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Psoriasis Vulgaris is a chronic, recurrent, inflammatory and hyperproliferative skin disease. Joint involvement is common along with skin involvement. However, metabolic diseases, such as cardiovascular diseases can be accompanied by many systemic diseases, chronic and repetitive due to the quality of life and psychological status of patients can affect. Today, although the treatment is repetitive, chronic and requires follow-up due to the disease patients can turn to alternative and complementary medicine techniques. In recent years, studies on alternative medicine and complementary therapies have been noted in the medical literature. These studies also include Case Reports related to psoriasis vulgaris. However, in our country, there is no study that tells us whether patients with psoriasis vulgaris apply these treatments or not and what the practitioners think about the success of the treatment. The aim of the study will be to clarify issues such as whether patients with Psoriasis Vulgaris apply alternative medicine and complementary therapies for their disease.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1618
• Est. completion date: July 1, 2020
• Est. primary completion date: July 1, 2020
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• psoriasis vulgaris patients

Exclusion Criteria:

• the patients that don't want to answer the questions

Related Conditions & MeSH terms

• Psoriasis
• Psoriasis Vulgaris

Locations

Country	Name	City	State
Turkey	Melek Aslan Kayiran	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Alternative medicine and complementary therapies that psoriasis vulgaris patients apply without informing the doctor, how they learn these techniques, what make them use these techniques for their illness		July 2020